Tests how lymph node surgery choices affect lung nodule outcomes
Part of Cancer, Lungs & breathing clinical trials.
This study looks at whether different lymph node removal methods during lung surgery change outcomes for certain abnormal lung spots. It focuses on ground-glass nodules that stay the same after treatment-free observation and have a mostly solid portion on CT.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 to 75
- Your lung CT shows a ground-glass nodule (GGO) that does not shrink after 3 months of recheck CT
- The largest part of the GGO is under 3 cm across
- More than 50% of the GGO is a solid-looking part on CT
- Your doctors say you can safely have a lobectomy (removal of part of the lung)
- You agree to follow the study plan and sign written consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial studies whether a procedure called “ablation” is safe and effective for certain lung cancers that appear as ground-glass spots on CT scans and do not improve after 3 months. It may help people who cannot fully have surgery for their condition.
This study looks at whether removing lymph nodes in different ways improves outcomes for people with a specific kind of lung nodule seen on CT (a “ground-glass” spot with a mostly solid part). You may qualify if you are planning lung surgery and the CT measurements match the study’s exact thresholds.
This trial compares removing fewer lymph nodes during surgery for early-stage non-small cell lung cancer. It is for people with a small tumor (2 cm or less) that has both solid and ground-glass parts.
This study looks at whether people with a very early type of lung cancer can safely have curative surgery when their CT scan shows a ground-glass type spot with certain size and shape measurements. It aims to help doctors choose the right surgery approach based on the scan features and final pathology.
This trial is testing a lung-sparing surgery called segmentectomy for people with a certain type of lung cancer nodule. It aims to see if this surgery is a good option for those with solid-dominant nodules that are 2 to 3 cm in size and have not spread to lymph nodes.
This trial tests whether a more focused lymph node removal during surgery is safe and effective for people with a small, early-stage lung cancer (non-small cell type) located in the top part of the lung (apical segment).
Hear when a new Progression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.